Answers are grounded in this paper and cite their sources.
We developed an in-house indirect ELISA for relative measurement of IgG binding to the SARS-CoV-2 Spike receptor-binding domain (RBD; Omicron BA.1). Four antigen coating concentrations and three serum dilutions were evaluated using an internal convalescent-serum calibrator assigned arbitrary units (AU/mL). A coating concentration of 2 µg/mL and a serum dilution of 1:100 were selected. The calibration means showed a linear relationship (R² > 0.9999), although serum dilution responses did not demonstrate parallelism with the calibrator. Within-run OD-based coefficients of variation were 4.1–6.5%, and between-run AU-based coefficients of variation were 2.4–8.8% across three days with one operator. Background-derived analytical limits and an operational limit of quantification were characterised as preliminary estimates. In a pilot panel of 10 sera from patients with RT-PCR-confirmed infection and 10 pre-pandemic sera, the cut-off (0.134 OD₄₀₅; mean + 3 SD of the pre-pandemic sera) gave a sensitivity of 90.0% (95% CI 59.6–98.2%). The same negative sera were used to set the cut-off, thus the specificity was estimated by leave-one-out analysis and was 90.0% (59.6–98.2%), with an accuracy of 90.0% (69.9–97.2%). Apparent specificity at the fixed cut-off was 100%. The ROC AUC was 0.99 (95% CI 0.94–1.00). These findings support further development of a research serology platform, with independent clinical validation and calibration harmonisation needed before broader quantitative or diagnostic use.
No takes yet. Share an insight, caveat, or question.
Chahir et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: